CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: August 28, 2013
Result type: Reports
Project Number: SR0350
Product Line: Common Drug Review

Generic Name: Teriflunomide

Brand Name: Aubagio

Manufacturer: Genzyme Canada, a Division of Sanofi Aventis Canada Inc.

Indications: Multiple Sclerosis, relapsing

Submission Type: Pre-NOC

Project Status: Complete

Date Recommendation Issued: June 18, 2014

Recommendation Type: Do not list at the submitted price